Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia

被引：0

作者：

Pullarkat, Vinod ^{[1
,2
]}

Pratz, Keith W. ^{[3
]}

Doehner, Hartmut ^{[4
]}

Recher, Christian ^{[5
]}

Thirman, Michael J. ^{[6
]}

Dinardo, Courtney D.

Fenaux, Pierre ^{[8
,9
]}

Schuh, Andre C. ^{[10
]}

Wei, Andrew H. ^{[11
,12
]}

Pigneux, Arnaud ^{[13
]}

Jang, Jun-Ho ^{[14
]}

Juliusson, Gunnar ^{[15
]}

Miyazaki, Yasushi ^{[16
]}

Selleslag, Dominik ^{[17
]}

Arellano, Martha L. ^{[18
]}

Liu, Chenglong ^{[19
]}

Ridgeway, Jean A. ^{[19
]}

Potluri, Jalaja ^{[19
]}

Schuler, Jovita ^{[19
]}

Konopleva, Marina ^{[7
]}

机构：

[1] City Hope Comprehens Canc Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA

[2] City Hope Comprehens Canc Ctr, Gehr Family Ctr Leukemia Res, Duarte, CA 91010 USA

[3] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[4] Ulm Univ Hosp, Dept Internal Med 3, Ulm, Germany

[5] CHU Toulouse, Toulouse, France

[6] Univ Chicago Med, Dept Med, Sect Hematol Oncol, Chicago, IL USA

[7] Montefiore Einstein Comprehens Canc Ctr, Bronx, NY USA

[8] Hop St Louis, Assistance Publ Hop Paris, Paris, France

[9] Univ Paris, Paris, France

[10] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada

[11] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Peter MacCallum Canc Ctr, Melbourne, VIC, Australia

[12] Univ Melbourne, Melbourne, VIC, Australia

[13] CHU Bordeaux, Dept Hematol, Bordeaux, France

[14] Sungkyunkwan Univ, Samsung Med Ctr, Dept Hematol Oncol, Sch Med, Seoul, South Korea

[15] Skane Univ Hosp, Dept Hematol, Lund, Sweden

[16] Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, Atom Bomb Dis & Hibakusha Med Unit, Nagasaki, Japan

[17] Algemeen Ziekenhuis St Jan, Brugge, Belgium

[18] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA

[19] AbbVie Inc, N Chicago, IL USA

来源：

BLOOD CANCER JOURNAL | 2025年 / 15卷 / 01期

关键词：

D O I：

10.1038/s41408-025-01263-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 50 条

[1] Venetoclax and Azacitidine Combination in Chemotherapy Ineligible Untreated Patients with Therapy-related Myeloid Neoplasms, Antecedent Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Pullarkat, Vinod
Pratz, Keith W.
Doehner, Hartmut
Recher, Christian
Thirman, Michael J.
DiNardo, Courtney D.
Fenaux, Pierre
Schuh, Andre C.
Wei, Andrew H.
Pigneux, Arnaud
Jang, Jun-Ho
Juliusson, Gunnar
Miyazaki, Yasushi
Selleslag, Dominik
Arellano, Martha L.
Naqvi, Kiran
Yu, Jun
Ridgeway, Jean A.
Potluri, Jalaja
Konopleva, Marina
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 58 - 59
[2] Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia
Meers, S.
Selleslag, D.
Potier, H.
Glasmacher, A.
Mineur, P.
Voelter, V.
CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (01) : 35 - 42
[3] Venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with therapy-related myeloid neoplasms, antecedent myelodysplastic syndromes, or myelodysplastic/myeloproliferative neoplasms.
Pullarkat, Vinod
Pratz, Keith
Dohner, Hartmut
Recher, Christian
Thirman, Michael J.
Dinardo, Courtney Denton
Fenaux, Pierre
Schuh, Andre C.
Wei, Andrew H.
Pigneux, Arnaud
Jang, Jun Ho
Juliusson, Gunnar
Miyazaki, Kazuhito
Selleslag, Dominik
Arellano, Martha Lucia
Naqvi, Kiran
Yu, Jun
Ridgeway, Jean
Potluri, Jalaja
Konopleva, Marina
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[4] 5-Azacitidine Therapy in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia: a Single Institution Experience
Freyrie, Alessandra
Reda, Gianluigi
Vincenti, Daniele
Sciume, Mariarita
Binda, Francesca
Guidotti, Francesca
Cortelezzi, Agostino
BLOOD, 2012, 120 (21)
[5] Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment
Calleja, Anne
Yun, Seongseok
Moreilhon, Chimene
Karsenti, Jean Michel
Gastaud, Lauris
Mannone, Lionel
Komrokji, Rami
al Ali, Najla
Dadone-montaudie, Berangere
Robert, Guillaume
Auberger, Patrick
Raynaud, Sophie
Sallman, David A.
Cluzeau, Thomas
EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (05) : 488 - 498
[6] Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)
Freyrie, A.
Reda, G.
Vincenti, D.
Ferla, V.
Orofino, N.
Sciume, M.
Guidotti, F.
Cortelezzi, A.
LEUKEMIA RESEARCH, 2013, 37 : S157 - S158
[7] Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
Garcia-Manero, Guillermo
Gore, Steven D.
Cogle, Christopher
Ward, Renee
Shi, Tao
MacBeth, Kyle J.
Laille, Eric
Giordano, Heidi
Sakoian, Sarah
Jabbour, Elias
Kantarjian, Hagop
Skikne, Barry
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : 2521 - 2527
[8] Health-Related Quality of Life in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Receiving Glasdegib plus Azacitidine
Wang, Eunice
Bell, Timothy
Zeidan, Amer
Bhattcharyya, Helen
Kudla, Arthur
Chan, Geoffrey
Sekeres, Mikkael
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S191 - S191
[9] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
DiNardo, C. D.
Jonas, B. A.
Pullarkat, V.
Thirman, M. J.
Garcia, J. S.
Wei, A. H.
Konopleva, M.
Doehner, H.
Letai, A.
Fenaux, P.
Koller, E.
Havelange, V.
Leber, B.
Esteve, J.
Wang, J.
Pejsa, V.
Hajek, R.
Porkka, K.
Illes, A.
Lavie, D.
Lemoli, R. M.
Yamamoto, K.
Yoon, S. -S.
Jang, J. -H.
Yeh, S. -P.
Turgut, M.
Hong, W. -J.
Zhou, Y.
Potluri, J.
Pratz, K. W.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) : 617 - 629
[10] Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes
Shimony, Shai
Stone, Richard M.
Stahl, Maximilian
CURRENT OPINION IN HEMATOLOGY, 2022, 29 (02) : 63 - 73

← 1 2 3 4 5 →